Skip to main content
logo
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
29.00
-0.27 (-0.91%)
May 13, 2026, 11:16 AM EDT - Market open

Cue Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
943067125123364
Market Cap Growth
93.42%-56.21%-45.94%1.61%-66.32%-4.08%
Enterprise Value
71.224.6645.9383.560.44304.96
Last Close Price
29.009.1632.7079.2085.50339.30
PE Ratio
--1.09-1.51-2.38-1.91-8.02
PS Ratio
3.471.077.2622.7098.5324.38
PB Ratio
3.571.123.853.361.875.56
P/TBV Ratio
3.481.103.513.261.555.40
P/FCF Ratio
--1.35-1.85-3.12-2.92-9.16
P/OCF Ratio
--1.36-1.85-3.12-2.93-9.38
EV/Sales Ratio
2.590.174.9515.2148.5420.41
EV/EBITDA Ratio
--0.18-1.12-1.62-1.16-7.18
EV/EBIT Ratio
--0.18-1.11-1.60-1.14-6.98
EV/FCF Ratio
--0.21-1.26-2.09-1.44-7.67
Debt / Equity Ratio
0.090.090.060.200.210.08
Debt / EBITDA Ratio
-0.16-0.16-0.22-0.28-0.37-0.24
Debt / FCF Ratio
-0.19-0.19-0.24-0.37-0.46-0.25
Net Debt / Equity Ratio
-0.87-0.87-0.78-0.91-0.87-0.83
Net Debt / EBITDA Ratio
0.900.900.330.661.091.28
Net Debt / FCF Ratio
1.051.050.370.851.361.37
Asset Turnover
0.740.740.200.070.010.16
Quick Ratio
2.562.561.712.946.615.28
Current Ratio
2.742.741.843.016.685.35
Return on Equity (ROE)
-118.83%-121.11%-149.03%-98.73%-80.82%-61.16%
Return on Assets (ROA)
-72.74%-72.74%-88.56%-68.25%-60.94%-48.33%
Return on Invested Capital (ROIC)
-400.35%-400.36%-884.96%-740.38%-518.55%-408.82%
Return on Capital Employed (ROCE)
-112.46%-112.46%-131.85%-83.99%-70.80%-56.83%
Earnings Yield
-27.93%-91.68%-66.05%-42.05%-52.28%-12.47%
FCF Yield
-22.95%-74.09%-54.01%-32.06%-34.22%-10.91%
Buyback Yield / Dilution
-68.18%-68.18%-23.11%-28.35%-13.95%-9.05%
Total Shareholder Return
-68.18%-68.18%-23.11%-28.35%-13.95%-9.05%
Updated Mar 16, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q